Filing Details

Accession Number:
0000950170-25-075539
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-05-20 21:46:49
Reporting Period:
2025-05-20
Filing Date:
2025-05-20
Accepted Time:
2025-05-20 21:46:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1579428 Axsome Therapeutics Inc. AXSM Pharmaceutical Preparations (2834) 454241907
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1658379 Mark Coleman C/O Axsome Therapeutics, Inc.
One World Trade Center, 29Th Floor
New York NY 10007
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2025-05-20 3,000 $107.49 54,137 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 403,856 Indirect See Footnote
Footnotes
  1. Represents the sale of underlying shares of previously exercised stock options.
  2. Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $107.34 and $107.65.
  3. Such shares are held by an entity, of which the reporting person has voting and dispositive power, and therefore, the reporting person is deemed to be the indirect beneficial owner of such shares.